These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12115398)

  • 21. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
    Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lobular carcinoma in situ of the breast].
    Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
    Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathology and heredity of breast cancer in younger women.
    Marcus JN; Watson P; Page DL; Lynch HT
    J Natl Cancer Inst Monogr; 1994; (16):23-34. PubMed ID: 7999466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
    Wagner PL; Kitabayashi N; Chen YT; Shin SJ
    Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
    Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
    Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial risk for esophageal cancer: an updated epidemiologic study from Sweden.
    Ji J; Hemminki K
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):840-5. PubMed ID: 16678496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
    Vogel VG
    Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction mammaplasty specimens and occult breast carcinomas.
    Kakagia D; Fragia K; Grekou A; Tsoutsos D
    Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial risks for cervical tumors in full and half siblings: etiologic apportioning.
    Hemminki K; Chen B
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1413-4. PubMed ID: 16835346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database.
    Hemminki K; Chen B
    Melanoma Res; 2006 Apr; 16(2):191-5. PubMed ID: 16567975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
    Saltzstein SL
    Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial risks in in situ cancers from the Family-Cancer Database.
    Hemminki K; Vaittinen P
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):865-8. PubMed ID: 9796630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second cancers following in situ carcinoma of the breast.
    Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
    Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.
    Mathes RW; Malone KE; Daling JR; Porter PL; Li CI
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):67-72. PubMed ID: 18199712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive breast cancer following ductal and lobular carcinoma in situ of the breast.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Int J Cancer; 2005 Sep; 116(5):820-3. PubMed ID: 15838829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.